Pyxis Oncology, Inc. (PYXS)
1.96
+0.02
(+1.03%)
USD |
NASDAQ |
May 22, 16:00
1.96
0.00 (0.00%)
After-Hours: 20:00
Pyxis Oncology Shareholders Equity (Quarterly) : 31.27M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| NanoViricides, Inc. | 9.154M |
| Organogenesis Holdings, Inc. | 381.35M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Amgen, Inc. | 9.19B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 64.30M |
| Total Liabilities (Quarterly) | 33.03M |
| Debt to Equity Ratio | 0.5839 |
| Current Ratio | 2.757 |
| Net Debt Paydown Yield | 0.42% |